Insulin resistance linked to increased risk of aortic stenosis

A large new population study of men over 45 indicates insulin resistance may be an important risk factor for the development of the world’s most common heart valve disease – aortic stenosis (AS).

Third Time’s a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise.

As an investigational diabetes drug implant that promises better adherence faces FDA review for a third time, safety concerns ranging from adverse heart and kidney

September 21, 2023

Smidt Heart Institute at Cedars-Sinai opens Aortic Surveillance Clinic for patients with enlarged aortas

The Smidt Heart Institute at Cedars-Sinai has opened an Aortic Surveillance Clinic for the evaluation and long-term monitoring of patients with enlarged aortas, or aortic

December 26, 2023

Integra to buy J&J’s Acclarent for $275M

Dive Brief: Integra Lifesciences reached an agreement to buy Johnson & Johnson’s ear, nose and throat (ENT) subsidiary Acclarent for $275 million in cash, the

December 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.